Cellosaurus logo
expasy logo

Cellosaurus PC-1 [Human lung carcinoma] (CVCL_S978)

[Text version]
Cell line name PC-1 [Human lung carcinoma]
Synonyms PC 1; PC1
Accession CVCL_S978
Resource Identification Initiative To cite this cell line use: PC-1 [Human lung carcinoma] (RRID:CVCL_S978)
Comments From: Immuno-Biological Laboratories (IBL); Tokyo; Japan.
Population: Japanese.
Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
Sequence variations
  • Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly334Val (c.1001G>T); Zygosity=Unspecified (PubMed=10536175).
Disease Lung squamous cell carcinoma (NCIt: C3493)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Sex of cell Sex unspecified
Age at sampling Age unspecified
Category Cancer cell line
Publications

PubMed=758928; DOI=10.1038/bjc.1979.3; PMCID=PMC2009802
Mitsuru Kinjo, Kazunari Oka, S. Naito, Shin Kohga, Kenzo Tanaka, Shoichi Oboshi, Yoshihiro Hayata, Kosei Yasumoto;
Thromboplastic and fibrinolytic activities of cultured human cancer cell lines.
Br. J. Cancer 39:15-23(1979)

PubMed=3731100
Nobuo Hanai, Kenya Shitara, Hajime Yoshida;
Generation of monoclonal antibodies against human lung squamous cell carcinoma and adenocarcinoma using mice rendered tolerant to normal human lung.
Cancer Res. 46:4438-4443(1986)

PubMed=1847845; DOI=10.1007/BF00685110
Yasutsuna Sasaki, Tetsu Shinkai, Kenji Eguchi, Tomohide Tamura, Yuichiro Ohe, Tohru Ohmori, Nagahiro Saijo;
Prediction of the antitumor activity of new platinum analogs based on their ex vivo pharmacodynamics as determined by bioassay.
Cancer Chemother. Pharmacol. 27:263-270(1991)

PubMed=8385084; DOI=10.1111/j.1349-7006.1993.tb02851.x; PMCID=PMC5919128
Susumu Suzuki, Takashi Takahashi, Shigeo Nakamura, Koichi Koike, Yutaka Ariyoshi, Toshitada Takahashi, Ryuzo Ueda;
Alterations of integrin expression in human lung cancer.
Jpn. J. Cancer Res. 84:168-174(1993)

PubMed=10536175; DOI=10.3892/ijo.15.5.927
Takeshi Fujita, Masaharu Kiyama, Yoshio Tomizawa, Takashi Kohno, Jun Yokota;
Comprehensive analysis of p53 gene mutation characteristics in lung carcinoma with special reference to histological subtypes.
Int. J. Oncol. 15:927-934(1999)

PubMed=11583962; DOI=10.1016/S0002-9440(10)62521-7; PMCID=PMC1850523
Nobuhiro Haruki, Tomoko Harano, Akira Masuda, Tohru Kiyono, Takao Takahashi, Yoshio Tatematsu, Shigeki Shimizu, Tetsuya Mitsudomi, Hiroyuki Konishi, Hirotaka Osada, Yoshitaka Fujii, Takashi Takahashi;
Persistent increase in chromosome instability in lung cancer: possible indirect involvement of p53 inactivation.
Am. J. Pathol. 159:1345-1352(2001)

PubMed=12794755; DOI=10.1002/ijc.11184
Hideki Endoh, Yasushi Yatabe, Shigeki Shimizu, Kohei Tajima, Hiroyuki Kuwano, Takashi Takahashi, Tetsuya Mitsudomi;
RASSF1A gene inactivation in non-small cell lung cancer and its clinical implication.
Int. J. Cancer 106:45-51(2003)

PubMed=17511773; DOI=10.1111/j.1349-7006.2007.00507.x; PMCID=PMC11159702
Takashi Fukuyama, Yoshinobu Ichiki, Sousuke Yamada, Yoshiki Shigematsu, Tetsuro Baba, Yoshika Nagata, Makiko Mizukami, Masakazu Sugaya, Mitsuhiro Takenoyama, Takeshi Hanagiri, Kenji Sugio, Kosei Yasumoto;
Cytokine production of lung cancer cell lines: correlation between their production and the inflammatory/immunological responses both in vivo and in vitro.
Cancer Sci. 98:1048-1054(2007)

Cross-references
Encyclopedic resources Wikidata; Q54938382
Experimental variables resources EFO; EFO_0002842
Polymorphism and mutation databases Cosmic; 1089227
Cosmic; 1571733
Cosmic; 2645027
IARC_TP53; 11869
IARC_TP53; 21086
Entry history
Entry creation03-Feb-2014
Last entry update19-Dec-2024
Version number17